Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Alseres Pharmaceuticals Inc (ALSE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2010	12-2009
Assets
Current Assets
Cash & Cash Equivalents	114	17	136	99	315
Marketable Securities	207	881	27	N/A	N/A
Other current assets	0	0	0	96	39
TOTAL	$325	$900	$168	$209	$388

Non-Current Assets
PPE Net	N/A	1	3	48	106
Other Non-Current Assets	61	65	0	204	296
TOTAL	$61	$66	$3	$252	$403

Total Assets	$386	$966	$171	$461	$791

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	1,556	2,603	2,210	8,292	3,523
Accrued Expenses	N/A	N/A	N/A	66	52
Other current liabilities	13	60	N/A	N/A	N/A
TOTAL	$1,648	$10,067	$30,425	$42,288	$43,137

Non-Current Liabilities
Long Term Debt	7,820	N/A	N/A	N/A	N/A
Deferred Revenues	74	74	N/A	N/A	N/A
Other Non-Current Liabilities	434	16,403	348	5,459	5,163
TOTAL	$9,397	$17,620	$348	$5,459	$5,163

Total Liabilities	$11,045	$27,687	$30,773	$47,747	$48,300

Shareholders' Equity
Shares Outstanding, K	6	6	6	5	5
Common Shares	306	306	306	268	256
Retained earnings	-199,635	-198,694	-197,048	-194,166	-194,678
Other shareholders' equity	7	-309	-31	0	0
TOTAL	$-10,660	$-26,721	$-30,602	$-47,286	$-47,509

Total Liabilities And Equity	$386	$966	$171	$461	$791